Genentech Inc. Newsletter
-
Adding New Mechanistic Agents to SMA Treatment: the Phase 3 RESILIENT Study
13 May 2024 19:08 GMT
… (Zolgensma; Novartis) and risdiplam (Evrysdi; Genentech), were subsequently approved, giving patients …
-
Personalized Medicine Market Size to Boost USD 1002.37 Billion By 2031 | CAGR 7.09%
13 May 2024 14:13 GMT
…
• International Business Machines Corporation (IBM)
• Genentech, Inc.
• 23andMe, Inc.
Personalized Medicine …
-
Trailblazers, iconoclasts and breakthrough artists are coming to the Endpoints biotech summit — please join us
13 May 2024 12:32 GMT
… research and early development at Genentech four years ago, she set …
-
Pearce IP BioBlast w/e 10 May 2024
13 May 2024 12:22 GMT
… acquisition of Cimerli®, biosimilar to Genentech’s Lucentis® (ranibizumab), announced in …
-
Biotech sees more job cuts
13 May 2024 12:11 GMT
… interest in moving forward.
Sanofi, Genentech and Twenty Twenty Therapeutics also …
-
Recursion’s BioHive-2, Powered by NVIDIA GPUs, Joins World’s Top 35 Supercomputers
13 May 2024 11:58 GMT
… , including Bayer AG, Roche, and Genentech, is supported by a vast …
-
Thinking inside the box: How SmartLabs is transforming laboratories for modern science and accelerating innovation
13 May 2024 10:01 GMT
… . I started my career at Genentech, where I was focused on …
-
NVIDIA : Drug Discovery, STAT! NVIDIA, Recursion Speed Pharma R&D With AI Supercomputer
13 May 2024 09:33 GMT
… as Bayer AG, Roche and Genentech. Over time, it also amassed …
-
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?
13 May 2024 06:12 GMT
… by BioNTech and Roche/Genentech, are being tested in combination …
-
Cut or Keep Running? How Companies Respond to Failed Confirmatory Trials
13 May 2024 05:15 GMT
… hindered its confirmatory trial. And Genentech’s Tecentriq won accelerated approval …